Barclays Starts Alnylam Pharmaceuticals (ALNY) at Overweight
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $143.80 -1.55%
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Barclays initiated coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with an Overweight rating.
For an analyst ratings summary and ratings history on Alnylam Pharmaceuticals click here. For more ratings news on Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $105.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- B.Riley Resumes Taboola (TBLA) at Buy
- UBS Starts Intershop Holding AG (ISN:SW) at Sell
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
